(Q64121003)
Statements
Rituximab, Bendamustine and Lenalidomide in Patients With Aggressive B-cell Lymphoma Not Eligible for High Dose Chemotherapy or Anthracycline-Based Therapy. A Phase I/II Trial. (English)
0 references
September 2009
0 references
April 2014
0 references
49
0 references
18 year
0 references